📰 John Bluth News

Page 4 - John Bluth News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from John Bluth. Real-time updates on events, politics, business and more.

BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia

August 18, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Saudi Arabia United Arab Emirates United States John Bluth Catherine Collier Kyroulis Joe Henein

Source: apnews.com

BioCryst Pharmaceuticals (BCRX) Q2 2022 Earnings Call Transcript

August 5, 2022

BCRX earnings call for the period ending June 30, 2022.

United States Bill Sheridan Helen Thackray Jon Stonehouse Anthony Doyle Charlie Gayer

Source: fool.com

BioCryst to Present at Upcoming Investor Conference

July 15, 2022

RESEARCH TRIANGLE PARK, N.C., July 15, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will...

United States John Bluth Catherine Collier Kyroulis Biocryst Pharmaceuticals Biocryst Pharmaceuticals Inc Cryst Pharmaceuticals

Source: globenewswire.com

BioCryst Presents New Data Demonstrating Consistently Low Attack Rates Among HAE Patients After Switching to ORLADEYO® (berotralstat)

July 1, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Czech Republic United States John Bluth Catherine Collier Kyroulis Teresa Caballero William Sheridan

Source: apnews.com

BioCryst Selects Pint Pharma as Commercial Partner for

June 9, 2022

RESEARCH TRIANGLE PARK, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered...

United States John Bluth David Munoz Pharma Gmb Catherine Collier Kyroulis Charlie Gayer

Source: globenewswire.com